1. Home
  2. CTNT vs XRTX Comparison

CTNT vs XRTX Comparison

Compare CTNT & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheetah Net Supply Chain Service Inc.

CTNT

Cheetah Net Supply Chain Service Inc.

HOLD

Current Price

$0.04

Market Cap

4.0M

Sector

N/A

ML Signal

HOLD

Logo XORTX Therapeutics Inc.

XRTX

XORTX Therapeutics Inc.

HOLD

Current Price

$1.81

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTNT
XRTX
Founded
2016
2011
Country
United States
Canada
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
3.9M
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
CTNT
XRTX
Price
$0.04
$1.81
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
47.0M
395.4K
Earning Date
05-08-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
57.74
N/A
EPS
N/A
N/A
Revenue
$1,288,536.00
N/A
Revenue This Year
$42.49
N/A
Revenue Next Year
$22.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
182.69
N/A
52 Week Low
$0.02
$0.35
52 Week High
$4.21
$3.60

Technical Indicators

Market Signals
Indicator
CTNT
XRTX
Relative Strength Index (RSI) N/A 43.51
Support Level N/A $0.39
Resistance Level N/A $2.29
Average True Range (ATR) 0.00 0.28
MACD 0.00 -0.04
Stochastic Oscillator 0.00 26.88

Price Performance

Historical Comparison
CTNT
XRTX

About CTNT Cheetah Net Supply Chain Service Inc.

Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.

Share on Social Networks: